Investment analysts at StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Free Report) in a report released on Saturday. The firm set a “sell” rating on the stock.

A day after an ABC13 report uncovering why a serial child groper didn't appear on the state sex offender registry, the Texas ...

For California Highway Patrol officer Ricardo Ayala, saving passengers from a plane crash on Jan. 29 was just another day at ...

More than a year since opening its doors, the Ayala Group’s Healthway Cancer Care Hospital (HCCH) is keeping its target of ...

Texas intensifies the search for convicted sex offender Carlos Jose Ayala Morales, now on the state's most wanted fugitives ...

THE AYALA GROUP expects to finalize the sale of its telehealth platform, KonsultaMD, to Pangilinan-led Metro Pacific Health Tech Corp. (mWell) by the end of the month, according to the president of ...

Property giant Ayala Land Inc. posted double-digit growth in its bottom line in 2024 amid strong performance across its ...

Adam Ayala scored 10 points in the second half and pulled down nine rebounds to help propel St. Bonaventure past Blair and ...

Ayala Land International Sales, Inc. (ALISI), the global marketing arm of Ayala Land, has officially partnered with Island ...

Ayala Land Estates, Inc. (ALEI) and The Blue Leaf broke ground on The Blue Leaf at Arca South, a premier events venue set to ...